MEDNAX’s operating income was up 13.9 percent in the fourth quarter of fiscal 2014, and the company’s net income was up 11.9 percent, growing to $88 million.
“Our strong fourth quarter operating results concluded a very successful year for us, with double-digit growth in revenue, operating income and earnings per share,” said Roger J. Medel, MD, CEO of MEDNAX.
More articles on healthcare finance:
Top 5 strategic areas CFOs are tackling
West Penn Allegheny Health System narrows losses in 2014
Gilead’s profit surges to $3.5B
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
